A stable ovine congestive heart failure model. A suitable substrate for left ventricular assist device assessment.
Similarities in coronary circulation and heart size of sheep to that of humans are specific advantages of a sheep model of congestive heart failure (CHF). CHF was created in 11 sheep (51 +/- 4 kg) by selective sequential intracoronary injection of 90 microns microspheres under 1.5% isoflurane anesthesia. Hemodynamic characteristics were assessed at baseline, 4 weeks after establishment of CHF (ejection fraction [EF] < 35%, n = 11), and 26 weeks (n = 7) later. Baseline echocardiographic EF was 59 +/- 5% and fell to 26 +/- 5% after 5 +/- 2 embolizations. The left ventricular (LV) pressure-volume relationship showed stable decreases in LV end-systolic elastance (Ees) and preload recruitable stroke work. Intravenous infusion of dobutamine increased Ees from 2.8 +/- 1.7 to 4.3 +/- 2.2 and 4.5 +/- 1.4 mmHg/ml at heart rates of 140 and 160/min, respectively, at baseline. Increases of Ees (from 1.3 +/- 0.5 to 2.3 +/- 0.7 and 1.9 +/- 0.5 mmHg/ml at heart rates of 140 and 160/min, respectively) with dobutamine under CHF conditions did not exceed Ees values at baseline without dobutamine. This response to dobutamine infusion did not change 26 weeks after establishment of CHF. This stable ovine CHF model is proposed for studies on the long-term effects of cardiac assist devices.
Huang
Y
Y
Cooperative Research Centre for Cardiac Technology, Royal North Shore Hospital, St. Leonards (Sydney), Australia.
Kawaguchi
O
O
Zeng
B
B
Carrington
R A
RA
Horam
C J
CJ
Yuasa
T
T
Abdul-Hussein
N
N
Hunyor
S N
SN
D000818:Animals; D004195:Disease Models, Animal; D005069:Evaluation Studies as Topic; D006333:Heart Failure / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D006353:Heart-Assist Devices; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008863:Microspheres; D012756:Sheep; D013045:Species Specificity; D013997:Time Factors; D016277:Ventricular Function, Left